Filters
Sort results
Reset
Apply
Cat No. | Products Name | Name | Previous Name | Target | Format | Options | Order | quote |
|---|---|---|---|---|---|---|---|---|
Pre-Made Blinatumomab biosimilar, Bispecific T-Cell Engager, Anti-CD19;CD3E Antibody: Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic antibody |
Blinatumomab |
NA |
CD19,CD3E |
Bispecific T-Cell Engager |
||||
Pre-Made Coltuximab biosimilar, Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody |
Coltuximab |
NA |
CD19 |
Whole mAb ADC |
||||
Pre-Made Denintuzumab biosimilar, Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody |
Denintuzumab |
NA |
CD19 |
Whole mAb ADC |
||||
Pre-Made Duvortuxizumab biosimilar, Bispecific scFv with Crossover, Anti-CD19;CD3E antibody: Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic antibody |
Duvortuxizumab |
NA |
CD19,CD3E |
Bispecific scFv with Crossover |
||||
Pre-Made Inebilizumab biosimilar, Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody |
Inebilizumab |
NA |
CD19 |
Whole mAb |
||||
Pre-Made Loncastuximab biosimilar, Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody |
Loncastuximab |
NA |
CD19 |
Whole mAb ADC |
||||
Pre-Made Obexelimab biosimilar, Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody |
Obexelimab |
NA |
CD19 |
Whole mAb |
||||
Pre-Made Tafasitamab biosimilar, Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody |
Tafasitamab |
NA |
CD19 |
Whole mAb |
||||
Pre-Made Ensomafusp Biosimilar, Fusion Protein targeting CD19: Recombinant therapeutic protein targeting B4/CVID3 |
Ensomafusp |
NA |
CD19 |
Fusion Protein |
||||
Pre-Made Taplitumomab Paptox biosimilar, Fusion Protein, Taplitumomab-Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody s |
taplitumomab paptox |
NA |
CD19 |
Fusion Protein |
||||
Pre-Made Coltuximab Ravtansine Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody: Anti-B4/CVID3 therapeutic antibody Drug Conjugate |
coltuximab ravtansine |
NA |
CD19 |
Whole mAb ADC |
||||
Pre-Made Denintuzumab Mafodotin Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody: Anti-B4/CVID3 therapeutic antibody Drug Conjugate |
denintuzumab mafodotin |
NA |
CD19 |
Whole mAb ADC |
||||
Pre-Made Ensomafusp Alfa Alfaiosimilar, Bispecific, Anti-Cd19; Tnfrsf9 Antibody: Anti-B4/CVID3;ILA/4-1BB/CDw137 therapeutic antibody |
ensomafusp alfa |
NA |
CD19,TNFRSF9 |
Bispecific |
||||
Pre-Made Loncastuximab Tesirine Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody: Anti-B4/CVID3 therapeutic antibody Drug Conjugate |
loncastuximab tesirine |
NA |
CD19 |
Whole mAb ADC |
